Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 69Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 6Breast Neoplasms, Male 5Neoplasms 3Neoplasm Metastasis 3Urinary Bladder Neoplasms 2Inflammatory Breast Neoplasms 2Sleep Wake Disorders 1Risk Reduction Behavior 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Obesity 1Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1Mastodynia 1Glioma 1Fibrocystic Breast Disease 1Fibroadenoma 1Fatigue 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Desmoid Tumors 1Cystic Fibrosis 1Cystadenocarcinoma, Serous 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Metastatic 1

Interventions

enzalutamide 3pembrolizumab 1nilutamide 1bicalutamide 1apalutamide 1Vorinostat 1Tamoxifen 1Panobinostat 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bulbo-Spinal Atrophy, X-Linked × Tamoxifen × Clear all
NCT00365599 2014-11-21

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
43 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡